Adenomyosis Treatment & Management: Approach Considerations, Medical Care, Surgical Care

Sections

Adenomyosis

Treatment

Approach Considerations

The most important factor when considering treatment of a patient with adenomyosis is her desire for future fertility. The only definitive treatment for symptoms associated with adenomyosis is hysterectomy; however, this is not an option for patients who desire future fertility and may not be an option for patients who are poor surgical candidates. Additionally, because adenomyosis is still rarely definitively diagnosed before hysterectomy, treatment relies on a presumptive diagnosis. Surveillance for improvement is based on clinical presentation, with little ability for surveillance through imaging studies.

Medical Care

The medications most commonly used to treat symptoms of adenomyosis are anti-inflammatory medications and hormonal therapies. The most common class of anti-inflammatory medications used to treat menorrhagia are non-steroidal antiinflammatory drugs. These inhibit formation of prostaglandins, which are considered the primary mechanism of action in uterine pain. Hormonal therapies cause ovarian suppression, mainly through negative feedback on the hypothalamic-pituitary-ovarian axis. By suppressing ovarian function, hormonal stimualtion of adenomyotic tissue is suppressed.

Surgical Care

High Intensity Focused Ultrasound (HIFU)

HIFU is a conservative surgical method which allows patients to preserve their uterus. MRI or ultrasound imaging is used to visualize the uterus and direct high-intensity ultrasound beams at a targeted area within the myometrial tissue. These argeted ultrasound beams cause thermal ablation and necrosis. HIFU can be used on both focal and diffuse adenomyosis.^{[37, 38]}Patients treated with MRI-guided FUS have shown improvement in menorrhagia and dysmenorrhea, with a decrease in uterine size.^{[39, 40, 41]}

Uterine Artery Embolization (UAE)

Uterine artery embolization (UAE) has long been used as conservative treatment for women with symptomatic uterine fibroids. More recently, it has been considered as a treatment for symptomatic adenomyosis for women who are not candidates for surgical management. After UAE, patients with adenomyosis have reported significant improvement in dysmenorrhea, pelvic heaviness and urinary frequency.^[42]Mean uterine volume has consistently been shown to have a significant decrease after UAE.^{[43, 42]}Resolution of symptoms may last from 17 months to >4 years; however, the overall efficacy of UAE for adenomyosis remains unknown.^{[44, 43, 45]}

Adenomyomectomy

Although adenomyomas are focal areas of adenomyosis surrounded by myometrial hypertrophy, there is no well-defined plane between an adenomyoma and normal myometrium. Adenomyomectomy is a surgical option for adenomyomas and is performed in the same manner as a myomectomy. After the location of the adenomyoma has been identified as well as possible using imaging techniques, the adenomyoma can be removed via laparotomy or laparoscopy.^{[46, 47, 48]}For larger, more severe cases of adenomyoma and adenomyosis, wedge resection of the uterus can be performed.^[49]Multiple different techniques exist for uterine reconstruction after resection of diffuse adenomyosis or adenomyoma;^[50]however, few studies have been performed evaluating fertility after reconstruction.

Hysterectomy

Hysterectomy is currently considered the only definitive management for adenomyosis, and is still the recommended method if desired future fertility is not a factor. In many instances, adenomyosis is incidentally noted on histologic exam.

Consultations

Typically, because adenomyosis is confined to the uterus, diagnosis and management can be managed by an OB/GYN. For patients desiring surgical management, a gynecologist adept in hysterectomy should be involved. If a patient prefers management with a uterine artery embolization, Interventional Radiology must be consulted for evaluation and management. If a patient desires future fertility, she should be referred to a Reproductive Endocrinologist for counseling regarding expectations of future fertility and for discussion of fertility options.

Diet

Although a healthy diet is always recommended, no diet has been found to cause or prevent the development of adenomyosis. However, obesity has been identified as an independent risk factor associated with the presence of adenomyosis and endometriosis, possibly due to exposure to elevated estrogen levels^[51]. A healthy diet, therefore, may reduce the risk of obesity.

Activity

There are no known physical activities which may cause or prevent the development of adenomyosis. However, as mentioned previously, obesity has been identified as an independent risk factor associated with adenomyosis^[51]and may be prevented with appropriate diet and physical activity.

Prevention

By avoiding potential risk factors, the risk of developing adenomyosis may be reduced. Minimizing unnecessary estrogen exposure and uterine trauma may prevent the occurrence of inciting events. Suppression of ovulation may additionally prevent further maturation of existent adenomyotic implants and may prevent the initial development of adenomyosis.

Long-Term Monitoring

Long-term monitoring is not typically indicated. Conservative management can be continued without scheduled surveillance, and future management can be dictated by the patient's symptoms.

Medication

Jimenez-Ayala M., Jimenez-Ayala Portillo B., Iglesias Goy, E., Rios Vallejo, M. Cytology of the Normal Endometrium- Cycling and Postmenopausal. Endometrial Adenocarcinoma: Prevention and Early Diagnosis. Switzerland: Karger; 2008.
Bergeron C, Amant F, Ferenczy A. Pathology and physiopathology of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006 Aug. 20 (4):511-21. [Medline].
Pelvic Mass. Hoffman BL, Schorge JO, Bradshaw KD, Halvorson LM, Schaffer JI, Corton MM. Williams Gynecology. Third. New York, NY: McGraw-Hill;
Devlieger R, D'Hooghe T, Timmerman D. Uterine adenomyosis in the infertility clinic. Hum Reprod Update. 2003 Mar-Apr. 9 (2):139-47. [Medline].
Ferenczy A. Pathophysiology of adenomyosis. Hum Reprod Update. 1998 Jul-Aug. 4 (4):312-22. [Medline].
Leyendecker G, Wildt L, Mall G. The pathophysiology of endometriosis and adenomyosis: tissue injury and repair. Arch Gynecol Obstet. 2009 Oct. 280 (4):529-38. [Medline].
Yamamoto T, Noguchi T, Tamura T, Kitawaki J, Okada H. Evidence for estrogen synthesis in adenomyotic tissues. Am J Obstet Gynecol. 1993 Sep. 169 (3):734-8. [Medline].
Morassutto C, Monasta L, Ricci G, Barbone F, Ronfani L. Incidence and Estimated Prevalence of Endometriosis and Adenomyosis in Northeast Italy: A Data Linkage Study. PLoS One. 2016. 11 (4):e0154227. [Medline].
Taran FA, Stewart EA, Brucker S. Adenomyosis: Epidemiology, Risk Factors, Clinical Phenotype and Surgical and Interventional Alternatives to Hysterectomy. Geburtshilfe Frauenheilkd. 2013 Sep. 73 (9):924-931. [Medline].
Vercellini P, Viganò P, Somigliana E, Daguati R, Abbiati A, Fedele L. Adenomyosis: epidemiological factors. Best Pract Res Clin Obstet Gynaecol. 2006 Aug. 20 (4):465-77. [Medline].
Benagiano G, Brosens I, Habiba M. Adenomyosis: a life-cycle approach. Reprod Biomed Online. 2015 Mar. 30 (3):220-32. [Medline].
Parazzini F, Vercellini P, Panazza S, Chatenoud L, Oldani S, Crosignani PG. Risk factors for adenomyosis. Hum Reprod. 1997 Jun. 12 (6):1275-9. [Medline].
Genc M, Genc B, Cengiz H. Adenomyosis and accompanying gynecological pathologies. Arch Gynecol Obstet. 2015 Apr. 291 (4):877-81. [Medline].
Curtis KM, Hillis SD, Marchbanks PA, Peterson HB. Disruption of the endometrial-myometrial border during pregnancy as a risk factor for adenomyosis. Am J Obstet Gynecol. 2002 Sep. 187 (3):543-4. [Medline].
Vercellini P, Parazzini F, Oldani S, Panazza S, Bramante T, Crosignani PG. Adenomyosis at hysterectomy: a study on frequency distribution and patient characteristics. Hum Reprod. 1995 May. 10 (5):1160-2. [Medline].
Dueholm M. Uterine adenomyosis and infertility, review of reproductive outcome after in vitro fertilization and surgery. Acta Obstet Gynecol Scand. 2017 Jun. 96 (6):715-726. [Medline].
Parazzini F, Mais V, Cipriani S, Busacca M, Venturini P, GISE. Determinants of adenomyosis in women who underwent hysterectomy for benign gynecological conditions: results from a prospective multicentric study in Italy. Eur J Obstet Gynecol Reprod Biol. 2009 Apr. 143 (2):103-6. [Medline].
Bergholt T, Eriksen L, Berendt N, Jacobsen M, Hertz JB. Prevalence and risk factors of adenomyosis at hysterectomy. Hum Reprod. 2001 Nov. 16 (11):2418-21. [Medline].
Vercellini P, Consonni D, Dridi D, Bracco B, Frattaruolo MP, Somigliana E. Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis. Hum Reprod. 2014 May. 29 (5):964-77. [Medline].
Basak S, Saha A. Adenomyosis: still largely under-diagnosed. J Obstet Gynaecol. 2009 Aug. 29 (6):533-5. [Medline].
Alabiso G, Alio L, Arena S, Barbasetti di Prun A, Bergamini V, Berlanda N, et al. Adenomyosis: What the Patient Needs. J Minim Invasive Gynecol. 2016 May-Jun. 23 (4):476-88. [Medline].
Vercellini P, Ragni G, Trespidi L, Oldani S, Panazza S, Crosignani PG. Adenomyosis: a déjà vu?. Obstet Gynecol Surv. 1993 Dec. 48 (12):789-94. [Medline].
Committee on Practice Bulletins—Gynecology. Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol. 2012 Jul. 120 (1):197-206. [Medline].
Dueholm M, Lundorf E. Transvaginal ultrasound or MRI for diagnosis of adenomyosis. Curr Opin Obstet Gynecol. 2007 Dec. 19 (6):505-12. [Medline].
Bazot M, Cortez A, Darai E, Rouger J, Chopier J, Antoine JM, et al. Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology. Hum Reprod. 2001 Nov. 16 (11):2427-33. [Medline].
Champaneria R, Abedin P, Daniels J, Balogun M, Khan KS. Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy. Acta Obstet Gynecol Scand. 2010 Nov. 89 (11):1374-84. [Medline].
Nam JH, Lyu GS. Abdominal ultrasound-guided transvaginal myometrial core needle biopsy for the definitive diagnosis of suspected adenomyosis in 1032 patients: a retrospective study. J Minim Invasive Gynecol. 2015 Mar-Apr. 22 (3):395-402. [Medline].
Dueholm M, Lundorf E, Hansen ES, Sørensen JS, Ledertoug S, Olesen F. Magnetic resonance imaging and transvaginal ultrasonography for the diagnosis of adenomyosis. Fertil Steril. 2001 Sep. 76 (3):588-94. [Medline].
Reinhold C, McCarthy S, Bret PM, Mehio A, Atri M, Zakarian R, et al. Diffuse adenomyosis: comparison of endovaginal US and MR imaging with histopathologic correlation. Radiology. 1996 Apr. 199 (1):151-8. [Medline].
Novellas S, Chassang M, Delotte J, Toullalan O, Chevallier A, Bouaziz J, et al. MRI characteristics of the uterine junctional zone: from normal to the diagnosis of adenomyosis. AJR Am J Roentgenol. 2011 May. 196 (5):1206-13. [Medline].
Molinas CR, Campo R. Office hysteroscopy and adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006 Aug. 20 (4):557-67. [Medline].
Keckstein J. Hysteroscopy and adenomyosis. Contrib Gynecol Obstet. 2000. 20:41-50. [Medline].
Vercellini P, Trespidi L, Panazza S, Bramante T, Mauro F, Crosignani PG. Laparoscopic uterine biopsy for diagnosing diffuse adenomyosis. J Reprod Med. 1996 Apr. 41 (4):220-4. [Medline].
Jeng CJ, Huang SH, Shen J, Chou CS, Tzeng CR. Laparoscopy-guided myometrial biopsy in the definite diagnosis of diffuse adenomyosis. Hum Reprod. 2007 Jul. 22 (7):2016-9. [Medline].
Siegler AM, Camilien L. Adenomyosis. J Reprod Med. 1994 Nov. 39 (11):841-53. [Medline].
Hulka CA, Hall DA, McCarthy K, Simeone J. Sonographic findings in patients with adenomyosis: can sonography assist in predicting extent of disease?. AJR Am J Roentgenol. 2002 Aug. 179 (2):379-83. [Medline].
Struble J, Reid S, Bedaiwy MA. Adenomyosis: A Clinical Review of a Challenging Gynecologic Condition. J Minim Invasive Gynecol. 2016 Feb 1. 23 (2):164-85. [Medline].
Zhang L, Rao F, Setzen R. High intensity focused ultrasound for the treatment of adenomyosis: selection criteria, efficacy, safety and fertility. Acta Obstet Gynecol Scand. 2017 Jun. 96 (6):707-714. [Medline].
Fukunishi H, Funaki K, Sawada K, Yamaguchi K, Maeda T, Kaji Y. Early results of magnetic resonance-guided focused ultrasound surgery of adenomyosis: analysis of 20 cases. J Minim Invasive Gynecol. 2008 Sep-Oct. 15 (5):571-9. [Medline].
Yoon SW, Kim KA, Cha SH, Kim YM, Lee C, Na YJ, et al. Successful use of magnetic resonance-guided focused ultrasound surgery to relieve symptoms in a patient with symptomatic focal adenomyosis. Fertil Steril. 2008 Nov. 90 (5):2018.e13-5. [Medline].
Kim KA, Yoon SW, Lee C, Seong SJ, Yoon BS, Park H. Short-term results of magnetic resonance imaging-guided focused ultrasound surgery for patients with adenomyosis: symptomatic relief and pain reduction. Fertil Steril. 2011 Mar 1. 95 (3):1152-5. [Medline].
Kim MD, Kim S, Kim NK, Lee MH, Ahn EH, Kim HJ, et al. Long-term results of uterine artery embolization for symptomatic adenomyosis. AJR Am J Roentgenol. 2007 Jan. 188 (1):176-81. [Medline].
Wang S, Meng X, Dong Y. The evaluation of uterine artery embolization as a nonsurgical treatment option for adenomyosis. Int J Gynaecol Obstet. 2016 May. 133 (2):202-5. [Medline].
Smeets AJ, Nijenhuis RJ, Boekkooi PF, Vervest HA, van Rooij WJ, Lohle PN. Long-term follow-up of uterine artery embolization for symptomatic adenomyosis. Cardiovasc Intervent Radiol. 2012 Aug. 35 (4):815-9. [Medline].
Froeling V, Scheurig-Muenkler C, Hamm B, Kroencke TJ. Uterine artery embolization to treat uterine adenomyosis with or without uterine leiomyomata: results of symptom control and health-related quality of life 40 months after treatment. Cardiovasc Intervent Radiol. 2012 Jun. 35 (3):523-9. [Medline].
Chung YJ, Kang SY, Choi MR, Cho HH, Kim JH, Kim MR. Robot-Assisted Laparoscopic Adenomyomectomy for Patients Who Want to Preserve Fertility. Yonsei Med J. 2016 Nov. 57 (6):1531-4. [Medline].
Grimbizis GF, Mikos T, Zepiridis L, Theodoridis T, Miliaras D, Tarlatzis BC, et al. Laparoscopic excision of uterine adenomyomas. Fertil Steril. 2008 Apr. 89 (4):953-61. [Medline].
Morita M, Asakawa Y, Nakakuma M, Kubo H. Laparoscopic excision of myometrial adenomyomas in patients with adenomyosis uteri and main symptoms of severe dysmenorrhea and hypermenorrhea. J Am Assoc Gynecol Laparosc. 2004 Feb. 11 (1):86-9. [Medline].
Sun AJ, Luo M, Wang W, Chen R, Lang JH. Characteristics and efficacy of modified adenomyomectomy in the treatment of uterine adenomyoma. Chin Med J (Engl). 2011 May. 124 (9):1322-6. [Medline].
Younes G, Tulandi T. Conservative Surgery for Adenomyosis and Results: A Systematic Review. J Minim Invasive Gynecol. 2017 Jul 21. [Medline].
Trabert B, Weiss NS, Rudra CB, Scholes D, Holt VL. A case-control investigation of adenomyosis: impact of control group selection on risk factor strength. Womens Health Issues. 2011 Mar-Apr. 21 (2):160-4. [Medline].
Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev. 2015 Jul 30. CD001751. [Medline].
Garcia L, Isaacson K. Adenomyosis: review of the literature. J Minim Invasive Gynecol. 2011 Jul-Aug. 18 (4):428-37. [Medline].
Fedele L, Bianchi S, Frontino G. Hormonal treatments for adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2008 Apr. 22 (2):333-9. [Medline].
Fong YF, Singh K. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system. Contraception. 1999 Sep. 60 (3):173-5. [Medline].
Farquhar C, Brosens I. Medical and surgical management of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006 Aug. 20 (4):603-16. [Medline].
Bragheto AM, Caserta N, Bahamondes L, Petta CA. Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging. Contraception. 2007 Sep. 76 (3):195-9. [Medline].
Cho S, Choi YS, Yun BH, Chon SJ, Jung YS, Kim H, et al. Effects of levonorgestrel-releasing intrauterine system on lymphangiogenesis of adenomyosis. Am J Clin Pathol. 2015 Mar. 143 (3):352-61. [Medline].
Sheng J, Zhang WY, Zhang JP, Lu D. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis. Contraception. 2009 Mar. 79 (3):189-93. [Medline].
Cho S, Nam A, Kim H, Chay D, Park K, Cho DJ, et al. Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis. Am J Obstet Gynecol. 2008 Apr. 198 (4):373.e1-7. [Medline].
Ozdegirmenci O, Kayikcioglu F, Akgul MA, Kaplan M, Karcaaltincaba M, Haberal A, et al. Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis. Fertil Steril. 2011 Feb. 95 (2):497-502. [Medline].
Li L, Leng JH, Dai Y, Zhang JJ, Jia SZ, Li XY, et al. [A prospective cohort study on effects of levonorgestrel-releasing intrauterine system for adenomyosis with severe dysmenorrhea]. Zhonghua Fu Chan Ke Za Zhi. 2016 May 25. 51 (5):345-51. [Medline].
Streuli I, Dubuisson J, Santulli P, de Ziegler D, Batteux F, Chapron C. An update on the pharmacological management of adenomyosis. Expert Opin Pharmacother. 2014 Nov. 15 (16):2347-60. [Medline].
Khan KN, Kitajima M, Hiraki K, Fujishita A, Sekine I, Ishimaru T, et al. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy. Hum Reprod. 2010 Mar. 25 (3):642-53. [Medline].
Huang FJ, Kung FT, Chang SY, Hsu TY. Effects of short-course buserelin therapy on adenomyosis. A report of two cases. J Reprod Med. 1999 Aug. 44 (8):741-4. [Medline].
Akira S, Iwasaki N, Ichikawa M, Mine K, Kuwabara Y, Takeshita T, et al. Successful long-term management of adenomyosis associated with deep thrombosis by low-dose gonadotropin-releasing hormone agonist therapy. Clin Exp Obstet Gynecol. 2009. 36 (2):123-5. [Medline].
Akira S, Mine K, Kuwabara Y, Takeshita T. Efficacy of long-term, low-dose gonadotropin-releasing hormone agonist therapy (draw-back therapy) for adenomyosis. Med Sci Monit. 2009 Jan. 15 (1):CR1-4. [Medline].
Takebayashi T, Fujino Y, Umesaki N, Ogita S. Danazol suspension injected into the uterine cervix of patients with adenomyosis and myoma. Preliminary study. Gynecol Obstet Invest. 1995. 39 (3):207-11. [Medline].
Igarashi M, Abe Y, Fukuda M, Ando A, Miyasaka M, Yoshida M, et al. Novel conservative medical therapy for uterine adenomyosis with a danazol-loaded intrauterine device. Fertil Steril. 2000 Aug. 74 (2):412-3. [Medline].
Cobellis L, Razzi S, Fava A, Severi FM, Igarashi M, Petraglia F. A danazol-loaded intrauterine device decreases dysmenorrhea, pelvic pain, and dyspareunia associated with endometriosis. Fertil Steril. 2004 Jul. 82 (1):239-40. [Medline].
Badawy AM, Elnashar AM, Mosbah AA. Aromatase inhibitors or gonadotropin-releasing hormone agonists for the management of uterine adenomyosis: a randomized controlled trial. Acta Obstet Gynecol Scand. 2012 Apr. 91 (4):489-95. [Medline].
Kimura F, Takahashi K, Takebayashi K, Fujiwara M, Kita N, Noda Y, et al. Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist. Fertil Steril. 2007 Jun. 87 (6):1468.e9-12. [Medline].
Leyendecker G, Bilgicyildirim A, Inacker M, Stalf T, Huppert P, Mall G, et al. Adenomyosis and endometriosis. Re-visiting their association and further insights into the mechanisms of auto-traumatisation. An MRI study. Arch Gynecol Obstet. 2015 Apr. 291 (4):917-32. [Medline].
Benagiano G, Habiba M, Brosens I. The pathophysiology of uterine adenomyosis: an update. Fertil Steril. 2012 Sep. 98 (3):572-9. [Medline].
Taran FA, Stewart EA, Brucker S. Adenomyosis: Epidemiology, Risk Factors, Clinical Phenotype and Surgical and Interventional Alternatives to Hysterectomy. Geburtshilfe Frauenheilkd. 2013 Sep. 73 (9):924-931. [Medline].
Vercellini P, Viganò P, Somigliana E, Daguati R, Abbiati A, Fedele L. Adenomyosis: epidemiological factors. Best Pract Res Clin Obstet Gynaecol. 2006 Aug. 20 (4):465-77. [Medline].
Jeng CJ, Huang SH, Shen J, Chou CS, Tzeng CR. Laparoscopy-guided myometrial biopsy in the definite diagnosis of diffuse adenomyosis. Hum Reprod. 2007 Jul. 22 (7):2016-9. [Medline].

Media Gallery

MRI of fundal adenomyoma.
Photo of an adenomyoma dissecting through the uterine wall.
Ultrasound of an adenomyoma dissecting through the anterior uterine wall separate from the endometrial cavity.
Adenomyosis noted within thickened myometrium.

of 4

Adenomyosis Treatment & Management

Approach Considerations

Medical Care

Surgical Care

Consultations

Diet

Activity

Prevention

Long-Term Monitoring

About

Membership

Apps

WebMD Network

Editions

What to Read Next on Medscape

Adenomyosis Treatment & Management

Approach Considerations

Medical Care

Surgical Care

Consultations

Diet

Activity

Prevention

Long-Term Monitoring

References

Tables

Contributor Information and Disclosures

What would you like to print?

Find Us On

About

Membership

Apps

WebMD Network

Editions

What to Read Next on Medscape

Related Conditions and Diseases

Medscape Consult

News & Perspective

Tools

Most Popular Articles

Recommended